Newsfeeds Archive - Page 2 of 29

2 minute read

GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims

May 21, 12:48 PM

Valisure sues GSK accusing the company of hiding cancer risks linked to Zantac, potentially defrauding the U.S. government. This follows Valisure's 2019 tests showing Zantac forms a carcinogen, prompting a whistleblower lawsuit seeking billions in damages.

GSK

1 minute read

GSK’s Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows

By Vandana Singh

May 21, 8:31 AM

GSK announced results from phase 3 trials SWIFT-1 and SWIFT-2, showing depemokimab's efficacy and safety in reducing severe asthma exacerbations.

GSK

1 minute read

GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale

By Vandana Singh

May 17, 10:45 AM

GSK is fully exiting its position and will no longer hold any ordinary shares in Haleon, maker of Sensodyne toothpaste and Advil painkillers.

GSK

1 minute read

GSK Announces Intention To Sell ~385M Shares In Haleon

By Benzinga Newsdesk

May 16, 11:44 AM

GSK plc (LSE/NYSE: GSK) today announced that it intends to sell approximately 385m ordinary shares in Haleon, equivalent to approximately 4.2% of Haleon's issued share capital and representing GSK's entire shareholding in Haleon.

GSK

3 minute read

Penny Stocks

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe’s Pharma Game

By Upwallstreet

May 16, 8:51 AM

On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France, just ahead of this year’s “Choose Franc

ABB

2 minute read

Amazon Pours ~$1.3B Investment Into French Operations: Report

By Shivani Kumaresan

May 13, 6:20 AM

Amazon's €1.2 billion investment marks a significant stride in bolstering its French presence, promising 3,000 new jobs. The move aligns with France's push for tech investment, showcased at the 'Choose France' event, where giants like Amazon, GSK, and Accenture pledge substantial commitments. Amazon Web Services' expansion in Paris not only supports AI innovation but also caters to France's burgeoning startup ecosystem, propelled by Meta Platforms Inc and Google.

ACN

2 minute read

FDA Delays ‘Important’ Moderna Vaccine Review: William Blair Says 2025 Growth, ‘2026 Breakeven Story’ Depends On It

By Vandana Singh

May 10, 9:27 AM

FDA update: Moderna's BLA for mRNA-1345, RSV vaccine, may face delay past May 12 deadline. But no safety concerns reported.

GSK

2 minute read

Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2

By Avi Kapoor

May 9, 8:44 AM

As of May 9, 2024, five stocks in the health care sector could be flashing a real warning…

AZN

2 minute read

Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac

By Vandana Singh

May 8, 2:58 PM

Pfizer settles 10,000 Zantac lawsuits over cancer risks, but challenges remain. Details undisclosed. Sanofi's $100 million+ agreement also noted. Legal battles ongoing.

GSK

2 minute read

GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook

By Vandana Singh

May 1, 9:42 AM

Discover GSK's first-quarter performance, boasting a 10% Y/Y sales surge to £7.4 billion. Notable growth in Vaccines and Specialty Medicines, propelled by strong demand for Arexvy and Shingrix. Expectations soar with raised 2024 EPS and sales forecasts.

BNTX